Endocrinology

Hypothyroidism and pregnancy

Live Webinar

Hypothyroidism and pregnancy

E-learning Modules

Launch: 22 November 2024

Overview

The negative impact of thyroid hormone imbalances during conception and pregnancy on both mother and baby are well-documented. Despite the potential impact on the intellectual development of the baby, the diagnosis and treatment, particularly of subclinical hypothyroidism, is still controversial. This webinar will highlight the need for vigilance to case-find and monitor or treat women with hypothyroidism according to local guidelines.

The issue of trimester-specific reference ranges for thyroid stimulating hormone and free thyroid hormones that transcend inter-assay variability and other confounders (including ethnicity and iodine intake) [Gietka-Czernel, 2021] will also be discussed. Fixed reference ranges suggested by endocrine societies risk misclassifying some healthy pregnant women as hypothyroid, who are then treated unnecessarily, which can cause preterm delivery, gestational diabetes, hypertension and pre-eclampsia [Gietka-Czernel, 2021]. While treatment for subclinical hypothyroidism remains controversial, current recommendations do not support universal screening of low-risk women during pregnancy [Sullivan, 2019].

There is a high lifetime risk of developing permanent hypothyroidism post-partum in women with subclinical hypothyroidism before they were pregnant or who developed hypothyroidism in the first trimester [Peng, 2022]. The need for vigilance and periodic testing of these women will be discussed.

Learning Objectives

After this live webinar, participants will be able to:

Target Audience

Clinicians involved in endocrinology, particularly thyroid disorders and general practice; some content of interest to pediatricians, biochemists, clinical and research scientists, and those involved in pre-natal, pregnancy and post-natal care.

Language

English with simultaneous translation into Spanish and Chinese

Chair

Gabriela Brenta

Gabriela Brenta

Dr. Cesar Milstein Care Unit
Department of Endocrinology and Metabolism
Buenos Aires, Argentina

Faculty

Tim Korevaar

Tim Korevaar

Erasmus University Medical Centre
Rotterdam, The Netherlands
Kristien Boelaert

Kristien Boelaert

President-Elect of the British Thyroid Association (BTA)
Professor of Endocrinology
University of Birmingham
Birmingham, UK

Sign up for the module

Final Programme

Download Final Programme

· Gabriela Brenta ·

Gabriela Brenta, M.D., Ph.D., is an Assistant Professor at the Medical School of the University of Buenos Aires and a staff member of the Department of Endocrinology and Metabolism at Dr. Cesar Milstein Care Unit in Buenos Aires, where she coordinates the Thyroid Unit.

In June 2019, Dr. Brenta ended her term as President of the Latin American Thyroid Society (LATS), and in 2020 was engaged on behalf of LATS in the Scientific Committee of the 16th International Thyroid Congress and also in the Scientific Committee of the 19th International Congress of Endocrinology.

In 2022 she was included in the Scientific Committee of LATS Congress 2023 Curitiba, Brazil, and the Task Force of the American Thyroid Association Thyroid and Pregnancy Guidelines.

Dr. Brenta is also a member of the Argentine Society of Endocrinology and Metabolism (SAEM) with active participation in its Thyroid Department. Her areas of interest in clinical research include the cardiovascular and metabolic effects of thyroid hormones and the study of thyroid diseases, including nodular disease, in older adults.  Original papers and reviews have been published in Thyroid, Nature, and JCEM. She is also a member of the editorial board of Thyroid and Journal of Endocrinology Investigation.

· Martin O. Savage ·

Martin Savage is Emeritus Professor of Paediatric Endocrinology at William Harvey Research Institute, Barts and the London School of Medicine & Dentistry, Queen Mary, University of London. He was head of the Paediatric Endocrine Unit at Barts and the London School of Medicine from 1982 to 2007. He has interests in growth disorders, specifically those with abnormalities in the GH-IGF-1 axis and in phenotype-genotype relationships of GH-IGF-1 axis defects, notably GH resistance. He published the first human case of an IGF-1 gene defect in the New England Journal of Medicine in 1996.  His other interests are Cushing’s syndrome and growth in chronic inflammatory diseases. He was General Secretary of the European Society for Paediatric Endocrinology (ESPE) from 1997 to 2004. He has lectured in 61 countries and has published 472 original articles, reviews, textbook chapters and books. In 2007, he was awarded the ESPE Andrea Prader Prize for contributions to paediatric endocrinology and in 2018 he received a Visionary Award from the American Human Growth Foundation. In 2022, he received a Research Excellence Award from the Dr Sulaiman Al Habib Medical Journal in Riyadh, and the British Society of Paediatric Endocrinology & Diabetes James M. Tanner Lifetime Achievement Award. He continues to lecture nationally and internationally.